<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>19(9)</volume><submitter>Gatica-Garcia B</submitter><pubmed_abstract>JOURNAL/nrgr/04.03/01300535-202409000-00039/figure1/v/2024-01-16T170235Z/r/image-tiff Parkinsonism by unilateral, intranigral β-sitosterol β-D-glucoside administration in rats is distinguished in that the α-synuclein insult begins unilaterally but spreads bilaterally and increases in severity over time, thus replicating several clinical features of Parkinson's disease, a typical α-synucleinopathy. As Nurr1 represses α-synuclein, we evaluated whether unilateral transfected of rNurr1-V5 transgene via neurotensin-polyplex to the substantia nigra on day 30 after unilateral β-sitosterol β-D-glucoside lesion could affect bilateral neuropathology and sensorimotor deficits on day 30 post-transfection. This study found that rNurr1-V5 expression but not that of the green fluorescent protein (the neg</pubmed_abstract><journal>Neural regeneration research</journal><pagination>2057-2067</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11040301</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Unilateral rNurr1-V5 transgene expression in nigral dopaminergic neurons mitigates bilateral neuropathology and behavioral deficits in parkinsonian rats with α-synucleinopathy.</pubmed_title><pmcid>PMC11040301</pmcid><pubmed_authors>Luna-Herrera C</pubmed_authors><pubmed_authors>Mascotte-Cruz JU</pubmed_authors><pubmed_authors>Fernandez-Parrilla MA</pubmed_authors><pubmed_authors>Martinez-Fong D</pubmed_authors><pubmed_authors>Maldonado-Berny M</pubmed_authors><pubmed_authors>Gutierrez-Castillo ME</pubmed_authors><pubmed_authors>Valenzuela-Arzeta IE</pubmed_authors><pubmed_authors>Gatica-Garcia B</pubmed_authors><pubmed_authors>Lopez-Salas FE</pubmed_authors><pubmed_authors>Santoyo-Salazar J</pubmed_authors><pubmed_authors>Rodriguez-Oviedo CP</pubmed_authors><pubmed_authors>Reyes-Corona D</pubmed_authors><pubmed_authors>Espadas-Alvarez AJ</pubmed_authors><pubmed_authors>Bannon MJ</pubmed_authors><pubmed_authors>Soto-Rojas LO</pubmed_authors><pubmed_authors>Martinez-Davila IA</pubmed_authors><pubmed_authors>Escobedo L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Unilateral rNurr1-V5 transgene expression in nigral dopaminergic neurons mitigates bilateral neuropathology and behavioral deficits in parkinsonian rats with α-synucleinopathy.</name><description>JOURNAL/nrgr/04.03/01300535-202409000-00039/figure1/v/2024-01-16T170235Z/r/image-tiff Parkinsonism by unilateral, intranigral β-sitosterol β-D-glucoside administration in rats is distinguished in that the α-synuclein insult begins unilaterally but spreads bilaterally and increases in severity over time, thus replicating several clinical features of Parkinson's disease, a typical α-synucleinopathy. As Nurr1 represses α-synuclein, we evaluated whether unilateral transfected of rNurr1-V5 transgene via neurotensin-polyplex to the substantia nigra on day 30 after unilateral β-sitosterol β-D-glucoside lesion could affect bilateral neuropathology and sensorimotor deficits on day 30 post-transfection. This study found that rNurr1-V5 expression but not that of the green fluorescent protein (the neg</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2026-04-08T15:29:51.478Z</modification><creation>2026-04-08T04:48:25.612Z</creation></dates><accession>S-EPMC11040301</accession><cross_references><pubmed>38227536</pubmed><doi>10.4103/1673-5374.391190</doi></cross_references></HashMap>